Skip to main content
Premium Trial:

Request an Annual Quote

Genomatix to Annotate Promoters for Human Genome

Premium

Genomatix of Munich said it has initiated a project to annotate promoters for the entire human genome.

Using tools it developed, Genomatix said it can characterize large DNA sequences and predict functional promoters on a genomic scale. Promoters act as the molecular “switches” to regulate gene expression.

Genomatix said that based on the first published sequences from the human genome project (chromosomes 21 and 22) its approach is able to predict 50 percent of the previously characterized Polymerase II promoters from DNA sequences.

“From annotation of the two chromosomes (21, 22), we learned that about half of our independent predictions were confirmed by experimental evidence,” said Thomas Werner, CEO of Genomatix. “The fact that our methodology is very specific—low number of false positive predictions—will be of great importance to genome researchers.”

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.